Procurou por: STEMCELL TECHNOLOGIES

Código de Artigo: (STMC100-0139)

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Mouse monoclonal antibody against human, rhesus, cynomolgus CD63, unconjugated.

UOM: 1 * 100 µG

Promoção

 This is a MarketSource item. Additional charges may apply

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Mouse monoclonal IgG1, antibody against human, chimpanzee CD4, FITC-conjugated.

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Mouse monoclonal IgG2b, antibody against human, chimpanzee, CD45RA, Biotin-conjugated.

Código de Artigo: (STMC09915)

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Supplement for the expansion and differentiation of lymphoid progenitor cells.

UOM: 1 * 5 mL

Promoção

 This is a MarketSource item. Additional charges may apply

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: For detection and measurement of human interleukin 4.

Código de Artigo: (STMC100-0528)

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Serum-free media for maturation of branching lung organoids from human ES and iPS cells.

UOM: 1 * 1 KIT

Promoção

 This is a MarketSource item. Additional charges may apply

Código de Artigo: (STMC100-1068)

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Rabbit polyclonal antibody against human lysozyme.

UOM: 1 * 100 µl

Promoção

 This is a MarketSource item. Additional charges may apply

Código de Artigo: (STMC17894)

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Fast and easy isolation of human extracellular vesicles using immunomagnetic positive selection.

UOM: 1 * 1 KIT

Promoção

 This is a MarketSource item. Additional charges may apply

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: For estimation of CRISPR-Cas9 genome editing efficiency.

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Column-free immunomagnetic positive selection of human CD14+ cells for HLA analysis.

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Immunomagnetic positive selection of human EpCAM+ cells (e.g. mammary epithelial cells).

Código de Artigo: (STMC76013)

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Positive control for CRISPR-Cas9 genome editing.

UOM: 1 * 1 KIT

Promoção

 This is a MarketSource item. Additional charges may apply

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Column-free immunomagnetic positive selection of human CD19+ cells for HLA analysis

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Matrix for maintenance of human ES and iPS cells in combination with TeSR™ maintenance media.

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: Immunomagnetic isolation of untouched human monocytes

Novo produto

Fornecedor: STEMCELL TECHNOLOGIES

Descrição: The platelet-derived growth factor (PDGF) family has five heparin-binding members that assemble into four homodimers (PDGF-AA, PDGF-BB, PDGF-CC, and PDGF-DD) and one heterodimer (PDGF-AB; Li and Eriksson). PDGF signals through the receptor tyrosine kinases PDGFRα and PDGFRβ. It has been shown that PDGF-induced migration involves signaling pathways involving MEK/ERK, EGFR, Src and PI3K/AKT (Kim <i>et al.</i>). PDGF is a potent mitogen for cells of mesenchymal origin such as fibroblasts and vascular smooth muscle cells. PDGF has been implicated in pathogenesis of atherosclerosis, glomerulonephritis, cancer, and in the contraction of vascular smooth muscle cells of rat aortic tissues (Fretto <i>et al.</i>; Sachinidis <i>et al.</i>). PDGF-CC is secreted as a latent growth factor and requires activation by proteolytic processing (Li and Eriksson). PDGF-CC binds to PDGFRα homodimers and PDGFRαβ heterodimers, but not to PDGFRβ homodimers (Li and Eriksson). PDGF-CC is an angiogenic factor that stimulates coronary artery smooth muscle cell proliferation and plays a role in cardiovascular development (Gilbertson <i>et al.</i>). PDGF-CC is also expressed in many tumors and plays a role in tumorigenesis (Zwerner and May).

Novo produto